Tuesday, February 17, 2026

BTS Jimin Strikes Again: New Solo Track Hits U.K. Charts!

Jimin from BTS has entered the U.K....

‘RewawakeR;: LiSA and Felix’s Latest Collaboration Hits Streaming Platforms

LiSA collaborates with Stray Kids' Felix on "RewawakeR," a new single featuring multiple versions and showcasing her musical growth.

TOO CHICKEN To Fight: North Korea Is SHUSHED By South Korea’s Nuclear Subs Deal—Only Reporting On Russia’s Toys

North Korea monitors U.S.-South Korea nuclear submarine plans, reporting on Russia's new submarine launch amid rising tensions.

Tag: market

Northwell Health Partners with Rokit Healthcare: What This Means for Skin Cancer Treatment in 2026

Northwell Health partners with Rokit Healthcare to advance skin cancer regeneration and wound healing technologies in the U.S. market.

Limpid Clears U.S. Food and Drug Administration Registration, Targets $54B U.S. Pet Food Market With Freeze-Dried Launch

Bio pet food startup Limpid is set to officially launch its brand in the US market this month after completing preparations.

AI Medical Revolution: Waycen Partners with Dhafir Medical to Launch Waymed Endo in UAE

Waycen partners with Dhafir Medical to introduce AI endoscope in the UAE, enhancing healthcare training and expanding market presence.

Korean Spine-Implant Maker Targets Japan: L&K Biomed Showcases BluEX-LT at the Scoliosis Research Society Meeting

L&K Biomed showcased its products at the SRS conference in Japan, aiming to expand its market share in the APAC region, especially Japan.

Korean Medical AI Lands at the University of Washington: Neurofit Signs U.S. Deal for Brain MRI + PET Analysis Tools

Neurofit signs a contract to supply AI medical solutions to the University of Washington, marking its U.S. market entry and expansion.

Celltrion’s Remsima Surpasses 1 Trillion KRW in Sales for 2nd Consecutive Year: What’s Driving Its Success?

Celltrion's Remsima treatment surpasses 1 trillion KRW in sales, driven by European market growth and new liquid formulation.

Hyundai Motor Group Sweeps U.S. Media Awards: 17 Models Win Car and Driver Editors’ Choice for 2026

Hyundai Motor Company shines in the U.S. with 17 awards from Car and Driver, showcasing its competitive models and innovations.

Celltrion Gets Global IB Upgrades: Morgan Stanley Raises Target to $206.25 as New Biosimilars Lift Margins

Celltrion is expanding through biosimilars and new drug development, attracting global investor interest and raising target stock prices.

How VIEWORKS’ VISQUE DPS is Transforming Digital Pathology in Europe: A Game Changer for Hospitals

Vieworks secures a European contract for its VISQUE DPS slide scanner, enhancing its global presence in digital pathology diagnostics.

Rokit Healthcare Secures UAE Patent for AI-Based Cartilage Regeneration: A Game-Changer in Middle Eastern Joint Treatment

Rokit Healthcare secures a UAE patent for AI cartilage regeneration, targeting a $682M market and shifting focus to regenerative medicine.

How LG CNS and FuriosaAI Are Revolutionizing AI Infrastructure for the Public Sector

LG CNS partners with FuriosaAI to enhance AI services using neural processing units, targeting the public AI transformation market.

How Celltrion’s Omlyclo is Dominating Spain’s Omalizumab Market: A First-Mover Success Story

Celltrion's Omlyclo treatment is thriving in Spain, capturing over 60% of the omalizumab market with innovative strategies and strong demand.

GC Biopharma Corp Soars After Eight Years on the Back of Immunodeficiency Drug Alyglo, Posting Results in U.S. Market Push

GC Biopharma Corp breaks its fourth-quarter deficit with ALYGLO's success, achieving $106M in annual revenue and plans for future growth.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Top News

- Our Sponsors Ad -

Follow us